Potential Inhibitory Influence of miRNA 210 on Regulatory T Cells during Epicutaneous Chemical Sensitization.

Carrie Mae Long, Ewa Lukomska, Nikki B Marshall, Ajay Nayak, Stacey E Anderson
Author Information
  1. Carrie Mae Long: Immunology and Microbial Pathogenesis Graduate Program, West Virginia University, Morgantown, WV 26505, USA. clong14@mix.wvu.edu.
  2. Ewa Lukomska: Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Allergy and Clinical Immunology Branch, Morgantown, WV 26505, USA. uvm3@cdc.gov.
  3. Nikki B Marshall: Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Allergy and Clinical Immunology Branch, Morgantown, WV 26505, USA. nikki.marshall@inovio.com.
  4. Ajay Nayak: Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Allergy and Clinical Immunology Branch, Morgantown, WV 26505, USA. ajay.nayak@jefferson.edu.
  5. Stacey E Anderson: Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Allergy and Clinical Immunology Branch, Morgantown, WV 26505, USA. dbx7@cdc.gov.

Abstract

Toluene diisocyanate (TDI) is a potent low molecular weight chemical sensitizer and a leading cause of chemical-induced occupational asthma. The regulatory potential of microRNAs (miRNAs) has been recognized in a variety of disease states, including allergic disease; however, the roles of miRNAs in chemical sensitization are largely unknown. In a previous work, increased expression of multiple miRNAs during TDI sensitization was observed and several putative mRNA targets identified for these miRNAs were directly related to regulatory T-cell (T) differentiation and function including Foxp3 and Runx3. In this work, we show that miR-210 expression is increased in the mouse draining lymph node (dLN) and T subsets following dermal TDI sensitization. Alterations in dLN mRNA and protein expression of T related genes/putative miR-210 targets (foxp3, runx3, ctla4, and cd25) were observed at multiple time points following TDI exposure and in ex vivo systems. A T suppression assay, including a miR-210 mimic, was utilized to investigate the suppressive ability of T. Cells derived from TDI sensitized mice treated with miR-210 mimic had less expression of miR-210 compared to the acetone control suggesting other factors, such as additional miRNAs, might be involved in the regulation of the functional capabilities of these cells. These novel findings indicate that miR-210 may have an inhibitory role in T function during TDI sensitization. Because the functional roles of miRNAs have not been previously elucidated in a model of chemical sensitization, these data contribute to the understanding of the potential immunologic mechanisms of chemical induced allergic disease.

Keywords

References

  1. Biomed Res Int. 2014;2014:907420 [PMID: 24689063]
  2. Occup Environ Med. 2001 May;58(5):354-60, 290 [PMID: 11303086]
  3. J Immunotoxicol. 2011 Jan-Mar;8(1):1-2 [PMID: 21067469]
  4. Toxicol Appl Pharmacol. 2000 Jan 15;162(2):77-85 [PMID: 10637130]
  5. J Allergy (Cairo). 2011;2011:424203 [PMID: 21747867]
  6. Environ Health Perspect. 2007 Mar;115(3):328-35 [PMID: 17431479]
  7. Environ Health Insights. 2014 Dec 17;8(Suppl 1):51-62 [PMID: 25574139]
  8. J Allergy Clin Immunol. 2013 Jul;132(1):3-13; quiz 14 [PMID: 23735656]
  9. J Immunol. 2007 Aug 1;179(3):1864-71 [PMID: 17641053]
  10. Contact Dermatitis. 2012 Nov;67(5):298-305 [PMID: 22594804]
  11. Cell. 2009 Jan 9;136(1):26-36 [PMID: 19135886]
  12. Allergy. 2015 Sep;70(9):1121-9 [PMID: 25944053]
  13. J Exp Med. 2009 Oct 26;206(11):2329-37 [PMID: 19841090]
  14. Nat Immunol. 2014 Apr;15(4):393-401 [PMID: 24608041]
  15. Toxicol Sci. 2012 Jan;125(1):105-15 [PMID: 22003193]
  16. Nat Commun. 2015 Jul 13;6:7639 [PMID: 26165721]
  17. Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18704-9 [PMID: 19843690]
  18. Science. 2007 Apr 27;316(5824):604-8 [PMID: 17463289]
  19. Toxicol Sci. 2010 Jun;115(2):435-43 [PMID: 20176622]
  20. Immunity. 2009 Jan 16;30(1):80-91 [PMID: 19144316]
  21. Immunity. 2007 Feb;26(2):133-7 [PMID: 17307699]
  22. Nat Immunol. 2009 Dec;10(12):1252-9 [PMID: 19838199]
  23. Nat Immunol. 2008 Aug;9(8):839-45 [PMID: 18645592]
  24. Nat Rev Immunol. 2008 Feb;8(2):120-30 [PMID: 18204468]
  25. Clin Exp Immunol. 2010 Jun;160(3):489-97 [PMID: 20345975]
  26. Toxicol Sci. 2016 Jul;152(1):85-98 [PMID: 27103660]
  27. PLoS One. 2013 Jul 02;8(7):e67760 [PMID: 23844087]
  28. Toxicol Appl Pharmacol. 1981 Apr;58(2):221-30 [PMID: 6264649]
  29. Clin Exp Immunol. 2015 Mar;179(3):485-99 [PMID: 25302741]
  30. FEBS Lett. 2012 Apr 24;586(8):1201-7 [PMID: 22575656]
  31. Contact Dermatitis. 2000 Mar;42(3):123-7 [PMID: 10727161]
  32. J Immunotoxicol. 2014 Jul-Sep;11(3):250-9 [PMID: 24063594]

Word Cloud

Created with Highcharts 10.0.0TmiR-210TDImiRNAssensitizationchemicalexpressionregulatorydiseaseincludingdiisocyanatepotentialallergicrolesworkincreasedmultipleobservedmRNAtargetsrelatedfunctiondLNfollowingmimicCellsfunctionalToluenepotentlowmolecularweightsensitizerleadingcausechemical-inducedoccupationalasthmamicroRNAsrecognizedvarietystateshoweverlargelyunknownpreviousseveralputativeidentifieddirectlyT-celldifferentiationFoxp3Runx3showmousedraininglymphnodesubsetsdermalAlterationsproteingenes/putativefoxp3runx3ctla4cd25timepointsexposureexvivosystemssuppressionassayutilizedinvestigatesuppressiveabilityderivedsensitizedmicetreatedlesscomparedacetonecontrolsuggestingfactorsadditionalmightinvolvedregulationcapabilitiescellsnovelfindingsindicatemayinhibitoryrolepreviouslyelucidatedmodeldatacontributeunderstandingimmunologicmechanismsinducedPotentialInhibitoryInfluencemiRNA210RegulatoryEpicutaneousChemicalSensitizationimmunotoxicologyisocyanatemicroRNAcelltoluene

Similar Articles

Cited By